Normal view MARC view ISBD view

The third annual Northeastern Evolutionary Primatologists meeting at Yale University. [electronic resource]

By:

Fuchs, Amanda J

Contributor(s):

Publication details: Evolutionary anthropology Mar 2018Description: 68-70 p. digitalISSN:

1520-6505

Online resources:

Available from publisher's website

In: Evolutionary anthropology vol. 27

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: News

There are no comments on this title.

to post a comment.

Back to results

81 Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
by Postema, P T
82 Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
by Krenning, E P
83 Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
by De Jong, M
84 Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy.
by Ferone, D
85 Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
by Krenning, E P
86 Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
by de Herder, W W
87 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
by van Dijk, S C
88 Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
by Krenning, E P
89 Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
by Breeman, W A
90 A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
by Breeman, W A
91 The role of radioactive somatostatin and its analogues in the control of tumor growth.
by Krenning, E P
92 Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas.
by ten Bokum, A M
93 The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.
by Bodei, L
94 Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy.
by van Schaik, E
95 Visualization of the thymus by substance P receptor scintigraphy in man.
by van Hagen, P M
96 [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.
by van der Harst, E
97 The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.
by Van der Weerd, K
98 In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
by Breeman, W A
99 Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.
by Kwekkeboom, D J